RESCUNATE
Bifidobacterium Breve M-16 V Granules
Approved
Registration Information
- Food ID
- 8665
- Status
- Approved
- Application Type
- Generic/Biosimilars
- Classification
- Human
Product Information
- Active Ingredient
- Bifidobacterium Breve M-16 V Granules
- Strength
- Bifidobacterium breve M-16 V 1 Billion CFU
- Dosage Form
- Granules
- Route of Administration
- Oral
- Packaging
- 10X1X2 Sachets packed in Multilayered Laminate…
- Visual Description
- Off white coloured granules
- Shelf Life
- N/A
Manufacturer Information
- Manufacturer / Site
- Allianz Biosciences (P) Limited
- MAH (Marketing Authorization Holder)
- TABLETS MEDOPHARM PRIVATE LTD
- Country
- India
- Local / Foreign
- Foreign
Record Information
- Last Fetched
- 2026-02-28 03:14:35
- Last Updated
- 2026-11-04 03:15:26
Important Notice
This information is sourced from the Pharmacy and Poisons Board of Kenya. Always consult with a qualified healthcare professional before using any supplement.